WallStSmart
VECT

VectivBio Holding AG

NASDAQ: VECT · HEALTHCARE · PHARMACEUTICALS

$16.85
+0.00% today

Updated 2026-04-29

Market cap
$1.06B
P/E ratio
P/S ratio
21.08x
EPS (TTM)
$-2.10
Dividend yield
52W range
$0 – $0
Volume

WallStSmart proprietary scores

25
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
8.5
Quality
A
2.5
Profitability
F
5.0
Valuation
C+
4/9
Piotroski F-Score
Moderate
2.1
Altman Z-Score
Grey zone
Industry rank
View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target
$18.33
+8.78%
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

X-Ray snapshot

Strengths
+ Free cash flow $54.06M — positive
+ Debt/equity 0.05x — low leverage
Risks
- Thin margins at 0.00%

Key financials

Revenue Net Income Free Cash Flow
Metric2019202020212022TTM
Revenue$0.00$0.00$0.00$27.34M$27.34M
Net income$-23.53M$-60.50M$-87.01M$-93.73M$-28.48M
EPS$-2.10
Free cash flow$-14.95M$-38.30M$-72.20M$-56.33M$54.06M
Profit margin-342.84%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
VECT$1.06B254.32.55.08.5Avoid
LLY$789.69B7810.010.05.06.5Strong Buy
JNJ$547.64B594.79.03.36.0-41.97%Buy
ABBV$351.47B634.08.04.75.0-24.92%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

VectivBio Holding AG trades at $16.85. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 2.13, it sits in the grey zone. TTM revenue stands at $27.34M.

Frequently asked questions

What is VectivBio Holding AG's stock price?
VectivBio Holding AG (VECT) trades at $16.85.
Is VectivBio Holding AG overvalued?
Smart Value Score 25/100 (Grade F, Strong Sell).
What is the price target of VectivBio Holding AG (VECT)?
The analyst target price is $18.33, representing +8.8% upside from the current price of $16.85.
What is VectivBio Holding AG's revenue?
TTM revenue is $27.34M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
2.13 — grey zone.

Company info

SectorHEALTHCARE
IndustryPHARMACEUTICALS
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio21.08x
ROE-56.90%
Beta0.10
50D MA$15.86
200D MA$10.35
Shares out0.06B
Float0.03B
Short ratio
Avg volume

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years